EGFR and cancer prognosis.

[1]  L. Hennighausen,et al.  Transforming growth factor alpha and mouse models of human breast cancer , 2000, Oncogene.

[2]  M. J. van de Vijver,et al.  Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  S. Kitano,et al.  Immunohistochemical Study of c-erbB-2 Protein in Colorectal Cancer and the Correlation with Patient Survival , 1998, Oncology.

[4]  A. Tokunaga,et al.  Immunohistochemical demonstration of angiogenic growth factors and EGF receptor in hepatic metastases and primary human gastric cancer. , 1998, Nihon Ika Daigaku zasshi.

[5]  J. Koudstaal,et al.  Clinical relevance of transforming growth factor α, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors , 1998 .

[6]  Y. Yamashita,et al.  Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers. , 1998, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[7]  Hiroshi Yamamoto,et al.  Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features , 1998, Oncology.

[8]  A. Lenferink,et al.  Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.

[9]  S. Ranga,et al.  Comparative evaluation of cell proliferative indices and epidermal growth factor receptor expression in gastric carcinoma. , 1997, Indian journal of pathology & microbiology.

[10]  K. Pavelić,et al.  The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. , 1997, Gastroenterology.

[11]  R. Nicholson,et al.  erbB Signalling and Endocrine Sensitivity of Human Breast Cancer , 1997 .

[12]  H. Heinzl,et al.  EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. , 1997, Anticancer research.

[13]  G. Paludetti,et al.  Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. , 1996, British Journal of Cancer.

[14]  T. Yoshizaki,et al.  Prognostic Value of EGFR and TGF‐α in Early Laryngeal Cancer Treated With Radiotherapy , 1996 .

[15]  A. Yang,et al.  [The role of endoscopic ultrasonography and epidermal growth factor receptor assay in preoperative staging for gastric carcinoma]. , 1995, Zhonghua nei ke za zhi.

[16]  H. Sasano,et al.  Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma. , 1995, Human pathology.

[17]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[18]  T. Okuda,et al.  Clinical significance of epidermal growth factor (EGF), EGF receptor, and c‐erbb‐2 in human gastric cancer , 1995, Cancer.

[19]  D. Neal,et al.  Original Articles: Bladder Cancer , 1995 .

[20]  M. Leader,et al.  Cytoplasmic c‐erbB‐2 protein expression correlates with survival in Dukes' B colorectal carcinoma , 1994, Histopathology.

[21]  Henson Sw,et al.  Clinical study on epidermal growth factor and its receptor in human gastric cancer , 1994 .

[22]  I. Ellis,et al.  Transforming Growth Factor-α and Endocrine Sensitivity in Breast Cancer , 1994 .

[23]  H. Kawamata,et al.  In vitro and in vivo accelertration of the neoplastic phenotype of a low‐tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor‐α , 1994 .

[24]  K. Sugimachi,et al.  Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma. , 1994, Surgical oncology.

[25]  H. Ludwig,et al.  The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer , 1993, Cancer.

[26]  N. Quenville,et al.  Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer. , 1992, Surgical oncology.

[27]  J G Klijn,et al.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.

[28]  H. Takamura,et al.  Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer. , 1992, Oncology.

[29]  K. Takemura,et al.  [Immunohistochemical study on the expression of epidermal growth factor receptor (EGFR) in human colorectal carcinomas]. , 1991, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[30]  R. Steele,et al.  Epidermal growth factor receptor expression in colorectal cancer , 1990, The British journal of surgery.

[31]  K. Sugimachi,et al.  Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. , 1990, Cancer research.

[32]  Atsushi Ochiai,et al.  Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma , 1988, International journal of cancer.

[33]  Atsushi Ochiai,et al.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. , 1988, Cancer research.

[34]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.